DIRECTORIO DE DOCUMENTOS EDITADOS EN ABRIL 2010

Source:  DIRECTORIO DE DOCUMENTOS EDITADOS EN ABRIL 2010    Tag:  bovine polyomavirus
DIRECTORIO DE DOCUMENTOS EDITADOS EN ABRIL 2010

CIENCIAS MÉDICAS NEWS
CIENCIAS MÉDICAS APLICADAS
RESEARCH & CLINICAL DEVELOPMENT

http://elbiruniblogspotcom.blogspot.com
http://saludequitativa.blogspot.com
http://herenciageneticayenfermedad.blogspot.com

Consultas acumuladas desde enero 2009 a la fecha: 174.192
Discriminadas como sigue:
1. ARGENTINA: 28.377 [16,3%]
2. ESPAÑA: 28.262 [16,2%]
3. MÉXICO: 24.945 [14,3%]
4. U.S.A.: 17.157 [9,8%]
5. COLOMBIA: 10.383 [6.0%]
6. VENEZUELA: 10.090 [5,8%]
7. PERÚ: 10.022 [5,8%]
8. CHILE: 6.099 [3,5%]
9. ECUADOR: 4.381 [2,5%]
10. BOLIVIA: 3.194 [1,8%]
11. LOS DEMÁS: 31.282 [18.0%]
Total de consultas: 174.192


Documentos del mes de abril: 502
Documentos acumulados en 2010: 1.867
Documentos editados desde el inicio del blog: 6.372

ARCHIVO DEL BLOG
• ▼ 2010 (1867)
o ▼ abril (502)
1. Comparative-Effectiveness Study Confirms New Treat...
2. FDA Approves New Device for Adults with Severe and...
3. Alzheimer's Disease and Cognitive Decline: Structu...
4. Adding Coronary Calcium Score to Traditional Risk ...
5. Licensure of a High-Dose Inactivated Influenza Vac...
6. CONSUMO EXCESIVO DE ANTIBIÓTICOS - AMÉRICA LATINA
7. PESTE BUBÓNICA, BROTE FAMILIAR - PERÚ (CHICAMA)
8. INFECCIÓN NOSOCOMIAL, NEONATOS, MUERTES - BRASIL (...
9. WILL SEE YOU AGAIN
10. Management of Asthma (Adult and Pediatric) - VA/Do...
11. Estrogen and progestogen use in postmenopausal wom...
12. NGC - Compare - Comparison: MANAGEMENT OF GENITAL ...
13. Tobacco control.
14. Screening, diagnosis and referral for substance us...
15. Medical management of adults with osteoarthritis.
16. Medical management of adults with hypertension.
17. MORAXELLA, INFECCIÓN NOSOCOMIAL, CIRUGÍA OCULAR - ...
18. Screening and Treatment of Glaucoma
19. Most Young Women with Menopause-like Condition Ret...
20. NIH Study Confirms Location of Stem Cells Near Car...
21. Scientists Find Genes That Influence Brain Wave Pa...
22. FDA Changes Process for Medical Device Advisory Co...
23. Silk Helps Make Ultrathin Brain Interface - NIH Re...
24. Health Care Use May Account for Colorectal Cancer ...
25. Mom's Obesity Raises Newborn’s Heart Risk - NIH Re...
26. 2009-2010 Influenza Season Week 15 ending April 17...
27. Pandemic (H1N1) 2009 - update 97
28. Low back pain. Early management of persistent non-...
29. European Medicines Agency - Human Medicines - CHMP...
30. European Medicines Agency - Human Medicines - Refu...
31. European Medicines Agency - Refusals - Medicinal P...
32. European Medicines Agency - Refusals - Medicinal P...
33. Insulin glulisine - EPARs for authorised medicina...
34. Fulvestrant - EPARs for authorised medicinal prod...
35. Lenalidomide for the treatment of multiple myeloma...
36. Cetuximab for the treatment of recurrent and/or me...
37. Report of an EFNS task force on management of slee...
38. American Society of Clinical Oncology clinical pra...
39. Clinical practice guideline: hoarseness (dysphonia...
40. Vacuna de 1976 podría proteger a personas contra i...
41. ATSDR: Safeguarding Communities from Chemical Expo...
42. Somatic gene mutation and human disease other than...
43. Genomics in the Scientific Literature - Genetic Te...
44. Health Literacy Universal Precautions Toolkit
45. INFLUENZA, H1N1, EPIDÉMICA, COINFECCIÓN - ALTA MOR...
46. Current status on Alzheimer disease molecular gene...
47. "The Cancer Bond": Exploring the Formation of Canc...
48. Genomics in the Scientific Literature: A, B and C
49. Genomics in the Scientific Literature: Cancer
50. Genetic basis for health benefits of the 'Mediterr...
51. Scientists discover new genetic sub-code
52. PHG Foundation | Combating genetic predisposition ...
53. Obesity gene, carried by more than a third of the ...
54. Understanding genetic causes of mental retardation...
55. PHG Foundation | Non-medical DNA sequencing of par...
56. European Medicines Agency - Human Medicines - Refe...
57. European Medicines Agency - Human Medicines - Refe...
58. nilotinib - EPARs for authorised medicinal product...
59. pioglitazone / metformin - EPARs for authorised me...
60. Pioglitazone / glimepiride - EPARs for authorised ...
61. pioglitazone / metformin hydrochloride - EPARs fo...
62. Pioglitazone - EPARs for authorised medicinal prod...
63. Pioglitazone hydrochloride - EPARs for authorised ...
64. Protein C Agalsidase beta (recombinant human a-gal...
65. HANTAVIRUS, BROTE, MUERTES - CHILE (LOS RÍOS)
66. ADHD Linked To Interaction Of Genetics And Psychol...
67. High Risk Of Broad Range Of Seizure Disorders Link...
68. New Insight Into Parkinson's Disease
69. Gene variant may protect memory and thinking skill...
70. Shedding Light On The Genetic Regulation Of Growth...
71. New Genome Assemblies Based Solely On Next-Generat...
72. Repairing The Gene Responsible For Duchenne Muscul...
73. Scientists Reveal How Genetic Mutations May Cause ...
74. Gene may play key role in atherosclerosis and othe...
75. New explanation for cardiac arrest
76. New Genetic Framework Could Help Explain Drug Side...
77. A New Technology Era: Personalized Medicine For Ca...
78. Mutations directly identifiable in active genes
79. PHG Foundation | Early changes in gene expression ...
80. NCI Cancer Bulletin for April 20, 2010 - National ...
81. Ovarian Cancer Study Offers Vital Clues For New Th...
82. German Study Is First To Clearly Link Mutations In...
83. Common Genetic Variation Impacts Breast Cancer Dia...
84. Study Finds Gene Test Reveals Who Could Benefit Fr...
85. Genomic-Based Portrait That Predicts Liver Cancer ...
86. Routine Breast Cancer Biopsy Might Predict Lymph N...
87. New Molecular Subtype Of Brain Cancer Discovered B...
88. UAB researchers find 4 biomarkers important in col...
89. Removable methyl groups on specific genes of autis...
90. Pandemic 2009 Influenza A(H1N1) Virus Illness Amon...
91. Contagious Period for Pandemic (H1N1) 2009 | CDC E...
92. Bluetongue Virus in Wild Deer, Belgium | CDC EID
93. Nosocomial Outbreak of CCHF, Sudan | CDC EID
94. Adenovirus 36 DNA in Adipose Tissue | CDC EID
95. La Crosse Virus in Mosquitoes, Texas | CDC EID
96. Mutant Strain of Pandemic (H1N1) 2009 Virus | CDC ...
97. Unusual Assortment in Rotavirus Genomes | CDC EID
98. Kobuvirus in Domestic Sheep, Hungary | CDC EID
99. Mutant Strain of Pandemic (H1N1) 2009 Virus | CDC ...
100. CDC H1N1 Flu | In The News - Question & Answer: 20...
101. Traumatic Brain Injury in the United States
102. Guidance for Industry and FDA Staff: Acceptable Me...
103. FDA Launches Initiative to Reduce Infusion Pump Ri...
104. Questions and Answers on the Propofol Shortage
105. Principles of Drug Addiction Treatment
106. CRYPTOCOCCUS GATTII, EXTENSIÓN A NUEVAS ÁREAS GEOG...
107. HANTAVIRUS, BROTE FAMILIAR, MUERTES - ARGENTINA (S...
108. VIH/SIDA, SALMONELLA, MECANISMO DE SUSCEPTIBILIDAD...
109. DENGUE, CIRCULACIÓN SIMULTÁNEA DE 3 SEROTIPOS - PA...
110. European Medicines Agency - Human Medicines - CHMP...
111. Pneumococccal Conjugate Vaccine, the Netherlands |...
112. American Society of Clinical Oncology/College of A...
113. Fluoroquinolone-Resistant Typhoid, South Africa | ...
114. Sorbitol-fermenting Escherichia coli O157, Scotlan...
115. No Resistance Plasmid in Yersinia pestis, North Am...
116. Body Lice, Yersinia pestis Orientalis, and Black D...
117. Salmonella Senftenberg Infections and Fennel Seed ...
118. Increase in Pneumococcus Macrolide Resistance, USA...
119. Sticky Decisions: Peanut Butter in a Time of Salmo...
120. Vitamin D Deficiency and TB | CDC EID
121. Announcement: World Malaria Day --- April 25, 2010...
122. Seroprevalence of Herpes Simplex Virus Type 2 Amon...
123. Real Kids are Curious about Alcohol
124. NIDA Blending Conference Launches New Training App...
125. NIH-led Interagency Group Identifies Research Need...
126. Malaria Day April 25, 2010
127. NEISSERIA GONORRHOEAE, RIESGO DE MULTI-RESISTENCIA...
128. sunitinib malate - EPARs for authorised medicinal ...
129. Prevention of Alzheimer's Disease and Cognitive De...
130. Propylthiouracil-Boxed Warning Added
131. Initiative to Reduce Unnecessary Radiation Exposur...
132. Absolute numbers of lives saved and overdiagnosis ...
133. NEJM -- A Randomized Study of Alglucosidase Alfa i...
134. Elective Single Embryo Transfer Following In Vitro...
135. Cytomegalovirus Infection in Pregnancy // Clinical...
136. AUA - Clinical Guidelines
137. Screening for obesity in children and adolescents:...
138. Diarrhoea and vomiting in children. Diarrhoea and ...
139. Borderline personality disorder: treatment and man...
140. Coronary artery disease (CAD) clinical practice gu...
141. Glaucoma. Diagnosis and management of chronic open...
142. Treating High Cholesterol: A Guide for Adults
143. Capecitabine - EPARs for authorised medicinal prod...
144. Palonosetron (as hydrochloride) - EPARs for author...
145. infliximab - EPARs for authorised medicinal produc...
146. panitumumab - EPARs for authorised medicinal produ...
147. Cidofovir anhydrous - EPARs for authorised medicin...
148. Darbepoetin alfa - EPARs for authorised medicinal ...
149. Japanese encephalitis virus, inactivated - EPARs f...
150. FDA Statement on IOM Sodium Report
151. Irritable Bowel Syndrome << Frequently Asked Quest...
152. Anxiety Disorders << Frequently Asked Questions <<...
153. European Medicines Agency - Human Medicines - Orph...
154. SÍFILIS CONGÉNITA, MADRES DROGADICTAS, PROTITUCIÓN...
155. MALARIA, AUMENTO MARCADO DE CASOS - VENEZUELA (BOL...
156. Bovine Tuberculosis in Buffaloes, Southern Africa ...
157. Vitamin D Deficiency and TB | CDC EID
158. XDR TB, Burkina Faso | CDC EID
159. MRSA and Skin Infections, Alaska | CDC EID
160. Increase in Pneumococcus Macrolide Resistance, USA...
A. phagocytophilum from Rodents and Sheep, China |...
161. DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE
162. Agency for Healthcare Research and Quality (AHRQ) ...
163. Prevention and control of meningococcal disease. R...
164. Guideline for prevention of catheter-associated ur...
165. mecasermin - EPARs for authorised medicinal produ...
166. olanzapine (as pamoate monohydrate) - EPARs for au...
167. Prevention of Alzheimer's Disease and Cognitive De...
168. Guideline for management of the clinical stage 1 r...
169. Genome.gov | 2010 News Feature: Genetic Variant Gr...
170. A Brain-Recording Device that Melts into Place, Ap...
171. Long -Term Effects of Toxic Exposure in 9/11 Respo...
172. Expression of Proteins Linked to Poor Outcome in W...
173. Independent Panel to Present Alzheimer's Disease a...
174. Erlotinib
175. FDA Launches Medical Device and Radiation-Emitting...
176. Cholesterol Genes Tied to Age-Related Macular Dege...
177. "Heel-Stick" Test Misses Viral Cause of Hearing Lo...
178. Vitamins Fail to Help Blood Pressure Disorders of ...
179. Cryptosporidiosis Associated with Wildlife Center,...
180. Physician Awareness of Chagas Disease, USA | CDC E...
181. Rickettsiae in Gulf Coast Ticks | CDC EID
182. La Crosse Virus in Mosquitoes, Texas | CDC EID
183. Schistosomiasis, Upper Nile River | CDC EID
184. Important Notice RabAvert Rabies Vaccine (Rabies V...
185. WHO | Pandemic (H1N1) 2009 - update 96
186. European Medicines Agency - Human Medicines - Medi...
187. Pregnancy and Medicines << Frequently Asked Questi...
188. Genome remodelling in a basal-like breast cancer m...
189. Cancer Cell - A Small-Molecule Inhibitor of BCL6 K...
190. golimumab - EPARs for authorised medicinal product...
191. AEDES AEGYPTI, AUTOPISTA, IMPACTO EN DISPERSIÓN - ...
192. VIRUS DEL MOTEADO DEL PIMIENTO, POSIBLE INTERFEREN...
193. NEUMONÍA, BROTE EPIDÉMICO - PARAGUAY
194. Rapid Antigen Test for Pandemic (H1N1) 2009 Virus ...
195. Co-infection with Dengue Virus and Pandemic (H1N1)...
196. Cross-Reactive Antibodies to Pandemic (H1N1) 2009 ...
197. Possible Transmission of Pandemic (HIN1) 2009 Viru...
198. Mutant Strain of Pandemic (H1N1) 2009 Virus | CDC ...
199. Rapid Antigen Test for Pandemic (H1N1) 2009 | CDC ...
200. Influenza and Mass Gathering | CDC EID
201. Contagious Period for Pandemic (H1N1) 2009 | CDC E...
202. Historical Distribution and Molecular Diversity of...
203. Spread of Adenovirus to Geographically Dispersed M...
204. Genomics in the Scientific Literature [25] - Respi...
205. Genomics in the Scientific Literature [24] - Pharm...
206. Genomics in the Scientific Literature [23] - Obesi...
207. Genomics in the Scientific Literature [22] - Menta...
208. Genomics in the Scientific Literature [21] - Mater...
209. Genomics in the Scientific Literature [20] - Infec...
210. Genomics in the Scientific Literature [19] - Genet...
211. Genomics in the Scientific Literature [18] - Famil...
212. Genomics in the Scientific Literature [17] Epigeno...
213. Genomics in the Scientific Literature [16] - Diabe...
214. Genomics in the Scientific Literature [15] - Chron...
215. Genomics in the Scientific Literature [14] Cardiov...
216. Genomics in the Scientific Literature [13] - Cance...
217. Genomics in the Scientific Literature [12] - Autoi...
218. Genomics in the Scientific Literature [11] - Aging...
219. Recently Updated Advisory Committee Materials
220. Big science: The cancer genome challenge : Nature ...
221. Gene defect promotes aggressive forms of ovarian c...
222. PHG Foundation | Debate marks tenth anniversary of...
223. PHG Foundation | New genes associated with kidney ...
224. Powerful New Method Allows Scientists To Probe Gen...
225. EMBL-EBI Researchers Present Global Map Of Human G...
226. In Williams Syndrome, When Social Fear Is Missing,...
227. Researchers Refine DNA Testing For Predisposition ...
228. Brain-Imaging Study Supports The Relevance Of A Co...
229. Genetic Kidney Diseases: Single Gene Defects Repre...
230. Potential For Development Of New Diagnostic Tests
231. Colorectal Carcinoma And Leukemia-Related Protein ...
232. Scientists Find New Genetic Clue For Multiple Myel...
233. Nursing in Practice - Deafness gene found by resea...
234. DOTmed.com - In Autism, Evidence for Gene Expressi...
235. Drugs that affect methylation state of genes could...
236. Genetic Variation Cuts Osteoarthritis Risk
237. Additional Genes Associated with Age-Related Macul...
238. Polymorphisms in genes of interleukin 12 and its r...
239. NOROVIRUS, TRANSMISIÓN EN AVIONES - U.S.A.
240. DENGUE, MALARIA, AUMENTO MARCADO DE CASOS - VENEZU...
241. Medication Guides
242. National Summit on Neglected Infections of Poverty...
243. TB and HIV, Tijuana, Mexico | CDC EID
244. S. dysgalactiae subsp. equisimilis Bacteremia | CD...
245. Tropheryma whipplei and Gastroenteritis | CDC EID
246. From Theory into Practice: NIDA's Blending Confere...
247. Metabolic fingerprints offer fresh clues and a new...
248. Mutations directly identifiable in active genes
249. Personalized medicine for cancer patients in a new...
250. Decoding Breast Cancer Genomes
251. Decoding tumor genomes reveals clues to spread of ...
252. Clofarabine - EPARs for authorised medicinal produ...
253. deferasirox - EPARs for authorised medicinal produ...
254. eculizumab - EPARs for authorised medicinal produc...
255. hydroxycarbamide - EPARs for authorised medicinal ...
256. everolimus - EPARs for authorised medicinal produ...
257. plerixafor - EPARs for authorised medicinal produc...
258. Upcoming Webinar on Thursday, April 22: Bovine Spo...
259. fosaprepitant dimeglumine - EPARs for authorised m...
260. Multiple Health Behavior Changes in a Cancer Preve...
261. Reaching Staff, Parents, and Community Partners to...
262. Socioeconomic Status and Prevalence of Obesity and...
263. Health-Related Outcomes of Adverse Childhood Exper...
264. Chronic Disease and Its Risk Factors Among Refugee...
265. The MedWatch March 2010 Drug Safety Labeling Chang...
266. Family Structure and Childhood Obesity, Early Chil...
267. Racial/Ethnic Differences in Perceived Access, Env...
268. BMI and Physical Activity Among at-Risk Sixth- and...
269. Overreporting of Deaths From Coronary Heart Diseas...
270. Evaluating an Insurance-Sponsored Weight Managemen...
271. QuickStats: Percentage of Women Aged ≥18 Years Who...
272. Update: Influenza Activity --- United States, Augu...
273. Preliminary FoodNet Data on the Incidence of Infec...
274. Congenital Syphilis --- United States, 2003--2008
275. ustekinumab - EPARs for authorised medicinal produ...
276. human fibrinogen / human thrombin - EPARs for auth...
277. mycophenolate mofetil - EPARs for authorised medic...
278. abatacept - EPARs for authorised medicinal product...
279. Emedastine difumarate - EPARs for authorised medic...
280. Bevacizumab - EPARs for authorised medicinal produ...
281. Rituximab - EPARs for authorised medicinal product...
282. Oxybutynin - EPARs for authorised medicinal produc...
283. A Systematic Review of Loss-of-Heterozygosity Base...
284. NCTR Research Highlights
285. Un estudio muestra una gran variabilidad en los in...
286. DENGUE HEMORRÁGICO, MUERTES, INCREMENTO - COLOMBIA...
287. Questions and Answers About the HVP Recall
288. “Preventing Adverse Health Effects from Nanotechno...
289. Challenges and Barriers to Clinical Decision Suppo...
290. HIV/AIDS Update - Updated label information for Su...
291. Zoledronic acid [2] - EPARs for authorised medicin...
292. JAMA -- Abstract: Anticonvulsant Medications and t...
293. Asthma and COPD Inhalers That Contain Ozone-deplet...
294. aliskiren hemifumarate / hydrochlorothiazide - EP...
295. aliskiren [2] - EPARs for authorised medicinal pro...
296. aliskiren - EPARs for authorised medicinal product...
297. Traditional ‘Heel Stick’ Test Is Not an Effective ...
298. Experimental Immune-Boosting Drug Worsens TB in Mi...
299. ArrayTrack™ News
300. REDUCING THE RISK OF THROMBOSIS AND EMBOLISM DURIN...
301. Chronic hepatitis B: update 2009.
302. Alcoholic liver disease.
303. AASLD practice guidelines: the role of transjugula...
304. Seven Inhalers That Use CFCs Being Phased Out
305. Adrenergic modulation of focal adhesion kinase pro...
306. Telaprevir for Previously Treated Chronic HCV Infe...
307. CDRHNew
308. FDA Approves Pancreatic Enzyme Product, Pancreaze
309. Additional Genes Associated with Age-Related Macul...
310. Strategy Confirmed to Help Doctors Determine When ...
311. Experts begin their assessment of the response to ...
312. Songbird Genome Yields Insight Into Vocal Communic...
313. Impaired Brain Connections Traced to Schizophrenia...
314. Drug Abuse and Obesity Share Brain Mechanism
315. Manual for the Surveillance of Vaccine-Preventable...
316. Sodium oxybate - EPARs for human use
317. Targeting the Blood-Brain Barrier May Delay Progre...
318. Blood Products Advisory Update
319. mechlorethamine HCl for injection [Mustargen]
320. Entrevista a la Dra. Marcela Echavarría: III Simpo...
321. Estenosis de la arteria renal
322. Eritropoyetina: ¿cuáles son los beneficios? ¿cuále...
323. Valor agregado de la proteinuria como marcador pro...
324. Exposure to HIV-1 Directly Impairs Mucosal Epithel...
325. Dnmt1 and Dnmt3a maintain DNA methylation and regu...
326. Cargo recognition failure is responsible for ineff...
327. Autism Research
328. Zoledronic acid - EPARs for authorised medicinal p...
329. Genomics in the Scientific Literature [10] - Other...
330. Genomics in the Scientific Literature [9] - Ethica...
331. Genomics in the Scientific Literature [8] - Person...
332. Genomics in the Scientific Literature [7] - Geneti...
333. Genomics in the Scientific Literature [6] - Pharma...
334. Genomics in the Scientific Literature [5] - Family...
335. Genomics in the Scientific Literature [4] - Epigen...
336. Genomics in the Scientific Literature [3] - Chroni...
337. Genomics in the Scientific Literature [2] - Cardio...
338. Genomics in the Scientific Literature [1] - Cancer...
339. Selection on alleles affecting human longevity and...
340. New genetic risk factors for brain aneurysms ident...
341. PHG Foundation | Evaluating the evidence for newbo...
342. DNA does not make overweight inevitable, new study...
343. Genetic Form Of Anemia Defined Molecularly
344. Genome-Driven Diagnoses And Treatments May Be Acce...
345. New Tool Developed For DNA Research
346. Novel Therapy For Blindness Works Only When Specif...
347. Measures Of Genetic Risk For Alcohol Dependence Si...
348. Discovery Of New Approach For Identifying Smokers ...
349. The Association Between ATG16L1 And Inflammatory B...
350. Risk Of Crohn's Disease And Genetic Variants
351. Gene Discovery Could Lead To New Treatments For Ch...
352. Breast Cancer Patients With BRCA Mutations At 4x H...
353. Human Medicines - Herbal Medicinal Products - Adop...
354. Sildenafil citrate - EPARs for authorised medicina...
355. canakinumab - EPARs for authorised medicinal produ...
356. indacaterol maleate (2) - EPARs for authorised med...
357. indacaterol maleate - EPARs for authorised medicin...
358. CDC - Seasonal Influenza (Flu) - Weekly Report: In...
359. WHO | Pandemic (H1N1) 2009 - update 95
360. Recently Updated Advisory Committee Materials
361. CDC H1N1 Flu | 5 Things Caregivers of People with ...
362. Quality Library for Health Providers - AHRQ - Arti...
363. Clue to cause of motor neurone disease revealed in...
364. Only women with Western Swedish breast cancer gene...
365. Oral Phosphate Binders in Patients with Kidney Fai...
366. Cisplatin plus Gemcitabine versus Gemcitabine for ...
367. Lung Function in Rescue Workers at the World Trade...
368. Identifying Research Priorities for Clinical Preve...
369. Human Rabies --- Kentucky/Indiana, 2009
370. Vitamin C and E Supplements Do Not Reduce Risk for...
371. Sleep Apnea Tied to Increased Risk of Stroke
372. Nuevo estudio indica tasas altas de rehospitalizac...
373. Triclosan: What Consumers Should Know
374. Medication errors in acute cardiovascular and stro...
375. e-Boletín Drogas y Medicamentos N° 3
376. Risk of Newborn Heart Defects Increases with Mater...
377. Daptomycin - EPARs for human use
378. Encuentran la clave para minimizar el riesgo de la...
379. Red Bugs with No Drugs – Part 1
380. Cancer Research—Formaldehyde-Induced Cancers
381. Many minority patients do not receive or complete ...
382. New report shows vaginal birth after cesarean is s...
383. Cholesterol and diabetes drugs lead drug spending ...
384. Lack of time, resources to blame for primary care ...
385. Common sleep disorder contributes to work disabili...
386. Counseling education does not significantly boost ...
387. Providing customized clinical information to patie...
388. HIV patients with psychiatric disorders are less l...
389. Rotavirus was culprit in one-fourth of children's ...
390. Outpatient advice on pediatric medication safety i...
391. Neighborhood surroundings may affect whether child...
392. Neighborhoods, abuse, and anxiety contribute to lo...
393. Medication review technique may help identify drug...
394. Aging causes changes in the brain's white matter, ...
395. Many older adults with mental health problems do n...
396. Types and rates of fungal infections vary among gr...
397. Physicians need to be better educated about FDA-ap...
398. Nearly two-thirds of mothers with depression do no...
399. Stressed-out women may delay getting preventive ca...
400. Abused women have higher risks for numerous medica...
401. Women's lack of knowledge and mistrust play a role...
402. Chemotherapy that contains anthracyclines is assoc...
403. epoetin theta - EPARs for human use (2)
404. epoetin theta - EPARs for human use
405. retapamulin - EPARs for human use
406. Drug Information Update: Follow up to the Public H...
407. FDA Issues Warning Letters for Drugs Promoted in F...
408. Effects of treatment in women with gestational dia...
409. New Study Details High Rates of Rehospitalizations...
410. New Study Implicates Healthcare Utilization Rates,...
411. Interim Results: State-Specific Influenza A (H1N1)...
412. FDA Approves New Formulation for OxyContin
413. HMH March 2010
414. FDA Drug Safety Communication: Ongoing Safety Revi...
415. Medication Guides
416. FDA Approves First Biodegradable Sealant Patch for...
417. Laboratory Analysis and Application of Pharmacogen...
418. NGC - Expert Resources - Expert Commentary
419. Management of hip fracture in older people. A nati...
420. Early management of patients with a head injury. A...
421. Drug misuse: psychosocial interventions.
422. Water and enteral formula safety and stability. In...
423. Ordering and labeling of enteral nutrition. In: A....
424. Monitoring enteral nutrition administration. In: A...
425. Medication administration. In: A.S.P.E.N. enteral ...
426. Enteral nutrition administration. In: A.S.P.E.N. e...
427. Enteral formula (medical food) and infant formula ...
428. Enteral access devices: selection, insertion, and ...
429. Approved Risk Evaluation and Mitigation Strategies...
430. Evaluation and Recommendation of Pharmacopoeial Te...
431. Pandemic (H1N1) 2009 - update 94
432. Lactose Intolerance 2
433. Lactose Intolerance
434. Are You Getting Enough Calcium?
435. When Cells Face an Energy Crisis
436. Autism and Family History by Genomics and Health
437. New insights into the 3-D organization of the huma...
438. Will genetics ever have the promised impact on med...
439. Use of nanoparticles for cancer therapy and diagno...
440. Genetic susceptibility to lung cancer in non-smoke...
441. UNC Genetics Policy, Law, Medicine Expert Agrees W...
442. The Genes Involved In Cell Division In Humans Iden...
443. Common Copy Number Variations In Genes Unlikely To...
444. Surgical Options In Inherited Breast Cancer Show D...
445. Nanoparticles Switch Off Cancer Genes In Human Tum...
446. Rare ATM Gene Mutations, Plus Radiation, May Incre...
447. Autism Susceptibility Genes Identified
448. MECANISMOS MOLECULARES Y ESTRUCTURALES EN LA NEURO...
449. UPCOMING MEETINGS by FDA
450. PRODUCT SAFETY by FDA
451. Prolastin (Alpha1 Proteinase Inhibitor (Human)) Un...
452. Zemaira (Alpha1 Proteinase Inhibitor (Human)) Unti...
453. Clostridium difficile
454. Alfred Russel Wallace and the Antivaccination Move...
455. Evolution of Porcine Kobuvirus Infection, Hungary
456. Household Transmission of Pandemic (H1N1) 2009, Sa...
457. Use of Norovirus Genotype Profiles to Differentiat...
458. Reassortment of Human Rotavirus Gene Segments into...
459. Merkel Cell Polyomavirus in Cutaneous Swabs
460. Sympatric Occurrence of 3 Arenaviruses, Tanzania
461. Reemergence of Dengue in Mauritius
462. Hantavirus Pulmonary Syndrome, French Guiana
463. Fatal Human Case of West Nile Disease, Mexico, 200...
464. Pandemic (H1N1) 2009 in Breeding Turkeys, Valparai...
465. Pandemic (H1N1) 2009 Infection in Swine Herds, Man...
466. Influenza A Strain-Dependent Pathogenesis in Fatal...
467. Limited Susceptibility of Chickens, Turkeys, and M...
468. One Flu for One Health
469. Pandemic (H1N1) 2009 Risk for Nurses after Trivale...
470. Risk for Transmission of Pandemic (H1N1) 2009 Viru...
471. Dual Seasonal Patterns for Influenza, China
472. Rapid Emergence of Oseltamivir Resistance
473. Science & Research: ArrayTrack™ News
474. NCTR Research Highlights: Bioimaging of Neurotoxic...
475. Contagious period for pandemic (H1N1) 2009
476. Rapid influenza antigen test for diagnosis of pand...
477. CONTAMINACIÓN EN CIGARRILLOS
478. ENCEFALITIS DE SAN LUIS - ALERTA EPIDEMIOLÓGICA - ...
479. Avian Influenza Prevalence in Pigs, Egypt
480. Triple Reassortant Swine Influenza A (H3N2) Virus ...
481. Findings, Gaps, and Future Direction for Research ...
482. AHRQ Prevention Program - Opportunity for Public C...
483. LIBRARY TIP 51: Substance Abuse Treatment: Address...
484. TIP 51: Substance Abuse Treatment: Addressing the...
485. Pathways that Can Repair Brca1 Cancer Gene Mutatio...
486. Impaired Brain Connections Traced to Schizophrenia...
487. Emerging Infectious Diseases: two subjects
488. Songbird Genome Analysis Reveals New Insights Into...
489. QuickStats: Percentage of Adults Aged ≥18 Years Ev...
490. Interim Results: State-Specific Influenza A (H1N1)...
491. Interim Results: Influenza A (H1N1) 2009 Monovalen...
492. Surveillance for Human West Nile Virus Disease ---...
493. AHRQ's Health Services Research Career Development...
494. What does FDA require drug manufacturers to do to ...
495. Yann le Cam - (Part 3) Concluding remarks from Eur...
496. Yann le Cam - (Part 2) Concluding remarks from Eur...
497. Yann le Cam - (Part 1) Concluding remarks from Eur...
498. Patients in Rare Disease Research: An Industry Per...
499. Bridging patients and researchers to advance resea...
500. Patients Advancing Rare Disease Research. Intervie...
501. Why Rare Disease Research Matters
o ► marzo (510)
o ► febrero (345)
o ► enero (510)
• ► 2009 (4504)


ARCHIVO DEL BLOG
• ▼ 2010 (1365)
o ▼ marzo (510)
 510. ENTREVISTA-Asia enfrenta amenaza enfermedad por an...
 509. ▲ Recommended adult immunization schedule: United St...
 508. ► First-line Systemic Chemotherapy in the Treatment ...
 507. SOLUTIONS® wound care algorithm.
 506. ☼ Guidelines of care for the management of psoriasis...
 505. ▲ CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): PULM...
 504. ► Faecal incontinence: the management of faecal inco...
 503. ambrisentan - EPARs for human use
 502. Docetaxel - EPARs for human use [REVISIÓN Y ACTUAL...
 501. Iloprost - EPARs for human use
 500. clopidogrel hydrogen sulphate / acetylsalicylic ac...
 499. clopidogrel hydrogen sulphate / acetylsalicylic ac...